These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Hot zones. Fox CH Science; 1999 Apr; 284(5412):262-3. PubMed ID: 10232973 [No Abstract] [Full Text] [Related]
43. [Biosafety in laboratories concerning exposure to biological agents]. Vonesch N; Tomao P; Di Renzi S; Vita S; Signorini S G Ital Med Lav Ergon; 2006; 28(4):444-56. PubMed ID: 17380946 [TBL] [Abstract][Full Text] [Related]
44. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(34):540-2, 547-9. PubMed ID: 3018469 [No Abstract] [Full Text] [Related]
55. Microbiological hazards in laboratories can be controlled. Burton DJ Occup Health Saf; 1986 May; 55(5):37-8. PubMed ID: 3086785 [No Abstract] [Full Text] [Related]
56. Containment considerations for the biotechnology industry. Liberman DF; Fink R Occup Med; 1991; 6(2):271-83. PubMed ID: 2047977 [TBL] [Abstract][Full Text] [Related]
58. Health technology assessment: Choice between a cytotoxic safety cabinet and an isolator for oncology drug reconstitution in Tunisia. Boufaied M; Bouhlel M; Soussi MA; Lazreg O; Khrouf MR J Oncol Pharm Pract; 2021 Jul; 27(5):1132-1138. PubMed ID: 32838684 [TBL] [Abstract][Full Text] [Related]
59. [Protective strategy against human immunodeficiency virus and other retroviral infection on laboratory work]. Kitamura K; Yamazaki S Nihon Rinsho; 1993 Sep; 51 Suppl():517-21. PubMed ID: 8271429 [No Abstract] [Full Text] [Related]
60. Containment system for the preparation of vitrified-hydrated virus specimens. Jeng TW; Talmon Y; Chiu W J Electron Microsc Tech; 1988 Apr; 8(4):343-8. PubMed ID: 3199217 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]